Viewing Study NCT00482495


Ignite Creation Date: 2025-12-24 @ 1:13 PM
Ignite Modification Date: 2026-02-22 @ 5:22 PM
Study NCT ID: NCT00482495
Status: COMPLETED
Last Update Posted: 2011-05-11
First Post: 2007-06-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module